CompletedPhase 3

Initiation of Ovarian Stimulation With Recombinant-human FSH (Bemfola®) in the Late Follicular Phase

Belgium71 participantsStarted 2018-11-01

Plain-language summary

A randomised controlled open-label clinical trial to compare the outcome parameters after ovarian stimulation using recombinant-human FSH (follicle stimulating hormone), starting on day 2 of the cycle versus start in the late follicular phase of the cycle.

Who can participate

Age range18 Years – 36 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * oocyte donor patients * Age from 18 to 36 years * BMI 19 to 35 * Regular menstrual cycle length i.e. 24-35 days Exclusion Criteria: * Patients with AMH \<1.1 ng/ml and/or AFC\<7 * Patients with FNPO (Follicle Number Per Ovary) ≥ 19 and/ord AMH \>5ng/ml * Endometriosis grade 3-4 * Oligo-amenorrhea * Any untreated endocrine abnormality

What they're measuring

total amount of COC (cumulus-oocyte-complex)

Timeframe: at oocyte aspiration

Trial details

NCT IDNCT03767218

SponsorUniversitair Ziekenhuis Brussel

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-05-27

View on ClinicalTrials.gov More Infertility, Female trials